DelveInsight’s ‘Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast – 2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of psoriatic arthritis in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Key Takeaways from Psoriatic Arthritis Market Research Report
- The increase in Psoriatic Arthritis Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
- As per DelveInsight analysis, the Psoriatic Arthritis Market is anticipated to witness growth at a considerable CAGR.
- The leading Psoriatic Arthritis Companies working in the market include AbbVie, Amgen, Johnson & Johnson, Bristol, Myers Squibb Company, Celgene Corporation, Novartis, Eli Lilly and Company, and UCB Biosciences Inc., and others.
- Promising Psoriatic Arthritis Therapies in the various stages of development include NDI-034858, Alefacept, Methotrexate, Etanercept, UCB4940 40 mg, and others.
- April 2024:- Novartis Pharmaceuticals- A 28-week, Randomized, Double-blind, Active Controlled, Multicenter Study to Evaluate the Efficacy of Subcutaneously Administered Secukinumab Compared to Ustekinumab in Adult Patients With Psoriatic Arthritis and Failure of TNFα- Inhibitor Treatment (AgAIN).
- April 2024:- UCB Biopharma SRL- A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis. This is a study to assess the long-term safety, long-term efficacy and tolerability of bimekizumab administered subcutaneously (sc) in adult subjects with psoriatic arthritis (PsA).
Discover which therapies are expected to grab the Psoriatic Arthritis Market Share @ Psoriatic Arthritis Market Outlook
Psoriatic Arthritis Overview
Psoriatic arthritis is a type of arthritis that affects some people who have psoriasis, a chronic skin condition characterized by red, scaly patches. Psoriatic arthritis can cause inflammation in the joints, leading to pain, stiffness, and swelling. It typically affects the joints of the fingers, toes, wrists, knees, and ankles, but can also affect other joints and even the spine.
Psoriatic Arthritis Epidemiology Insights
The epidemiology section of Psoriatic Arthritis offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Psoriatic Arthritis Epidemiology trends @ Psoriatic Arthritis Epidemiological Insights
Psoriatic Arthritis Drugs Market
The Psoriatic Arthritis Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Psoriatic Arthritis signaling in Psoriatic Arthritis are likely to uncover new therapeutic targets and further expand treatment options for patients.
Psoriatic Arthritis Treatment Market Landscape
The Psoriatic Arthritis treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Psoriatic Arthritis has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Psoriatic Arthritis treatment guidelines, visit @ Psoriatic Arthritis Treatment Market Landscape
Psoriatic Arthritis Market Outlook
The report’s outlook on the Psoriatic Arthritis market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Psoriatic Arthritis therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Psoriatic Arthritis drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Psoriatic Arthritis market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.
Psoriatic Arthritis Drugs Uptake
The drug chapter of the Psoriatic Arthritis report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Psoriatic Arthritis.
Major Psoriatic Arthritis Companies
Several Psoriatic Arthritis Companies working in the market include AbbVie, Amgen, Johnson & Johnson, Bristol, Myers Squibb Company, Celgene Corporation, Novartis, Eli Lilly and Company, UCB Biosciences Inc., and others.
Learn more about the FDA-approved drugs for Psoriatic Arthritis @ Drugs for Psoriatic Arthritis Treatment
Scope of the Psoriatic Arthritis Market Report
- Coverage- 7MM
- Psoriatic Arthritis Companies- AbbVie, Amgen, Johnson & Johnson, Bristol, Myers Squibb Company, Celgene Corporation, Novartis, Eli Lilly and Company, and UCB Biosciences Inc., and others.
- Psoriatic Arthritis Therapies- NDI-034858, Alefacept, Methotrexate, Etanercept, UCB4940 40 mg, and others.
- Psoriatic Arthritis Market Dynamics: Psoriatic Arthritis Market Drivers and Barriers
- Psoriatic Arthritis Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Psoriatic Arthritis Drugs in development @ Psoriatic Arthritis Clinical Trials Assessment
Table of Content
1. Key Insights
2. Report Introduction
3. Psoriatic Arthritis Market Overview at a Glance
4. Executive Summary of Psoriatic Arthritis
5. Disease Background and Overview
6. Epidemiology and Patient Population
7. Patient Journey of Psoriatic Arthritis
8. Marketed Products
9. Emerging Therapies
10. Other Assets
11. Psoriatic Arthritis (PsA): Seven Major Market Analysis
12. SWOT Analysis
13. KOL Views
14. Unmet Needs
15. Market Access
16. Acronyms and Abbreviations
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Psoriatic Arthritis Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight